DIN 02518627 — MINJUVI 200 MG
MINJUVI is a powder for solution of Tafasitamab marketed by INCYTE CORPORATION. The full Tafasitamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02518627
- Brand name
- MINJUVI
- Active ingredient
- Tafasitamab
- Strength
- 200 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- INCYTE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- CD19-directed cytolytic monoclonal antibody (Fc-enhanced anti-CD19 antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.